Christopher S. Boerner
Chief Executive Officer at Bristol-Myers Squibb Company
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Bristol-Myers Squibb Company, 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Colgate-Palmolive Company May 8, 202699.1%
-
Bristol-Myers Squibb Company May 5, 202695.2%
-
Bristol-Myers Squibb Company May 6, 202592.8%
-
Bristol-Myers Squibb Company May 7, 202493.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Bristol-Myers Squibb Company | Option exercise | +2,964 | — | — |
| Nov 1, 2026 | Bristol-Myers Squibb Company | Other | +406 | — | — |
| Nov 1, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | −1,724 | $62.48 | $107,716 |
| May 11, 2026 | Colgate-Palmolive Company | Grant or award | +1,383 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +6,618 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | −743 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | −3,006 | $60.13 | $180,751 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +6,733 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | −727 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | −3,073 | $60.13 | $184,779 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +40,398 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | −19,835 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Shares withheld for tax | −10,518 | $60.13 | $632,447 |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Option exercise | +17,788 | — | — |
| Mar 10, 2026 | Bristol-Myers Squibb Company | Other | −8,734 | — | — |
Questions about Christopher S. Boerner
What boards is Christopher S. Boerner on?
Christopher S. Boerner sits on the boards of Bristol-Myers Squibb Company and Colgate-Palmolive Company.
What company is Christopher S. Boerner the CEO of?
Christopher S. Boerner is Chief Executive Officer of Bristol-Myers Squibb Company.
How long has Christopher S. Boerner served on boards?
Our records show at least 3 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.